comprehensive -WSS

comprehensive

author：fashion 2025-10-02 12:41:51 - browse：1635

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Monday approved a gene therapy for metachromatic leukodystrophy, a devastating genetic disorder that eats away at affected children’s neurons.

The medicine, marketed as Lenmeldy, is the first treatment for MLD, which is otherwise fatal. Lenmeldy has to be given before symptoms appear or, in some cases, after the first signs of disease, so it won’t be helpful for many patients living with MLD today. But when given in time, it appears to be near-curative, allowing some children to grow up and attend school with unaffected peers.

Lenmeldy is already marketed in Europe, under the name Libmeldy, and has helped a handful of patients in the U.S. who were treated under compassionate use, as their doctors feared they didn’t have time to wait for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Readers respond to H5N1 and livestock movements, and more

focus

WSS

STAT Summit: Meghan O’Rourke on making chronic illness visible

NVIDIA and Google execs on the future of AI and drug discovery

Roche drug slashes death risk in early

Results on Novartis prostate cancer therapy could expand its use

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Results on Novartis prostate cancer therapy could expand its use

explore

comprehensive

Wikipedia

Medical records are filled with copy

Cytokinetics CEO stresses company can launch heart drug on its own

Heart attack and stroke risk calculators need revising

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Cancer drug shortages should be causing more outrage

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Bright Health sells Medicare Advantage business to Molina

NVIDIA and Google execs on the future of AI and drug discovery

Apple is now the first public company to be valued at $3 trillion

When prostate cancer spreads, where it goes matters

focus

Criminal prosecution for violating HIPAA: an emerging threat

STAT Readout Newsletter: Biotech news today

J&J lung cancer data amount to new salvo against AstraZeneca

Is there really a nursing shortage in the U.S.?

Readout LOUD podcast: Live from STAT Breakthrough Summit West

STAT Summit: How researchers deal with rejection

explore

focus

explore

Wikipedia